Download the article.patent
View Tag Index
| Do Reverse Payment Settlements Violate the Antitrust Laws? - 667 occurances |
| Efficient Definition and Communication of Patent Rights: The Importance of Ex Post Delineation - 613 occurances |
| Common Sense: Treating Statutory Nonobviousness As a Novelty Issue - 538 occurances |
| Common Sense: Treating Statutory Nonobviousness As a Novelty Issue - 538 occurances |
| Slaying the Troll: Litigation as an Effective Strategy Against Patent Threats - 523 occurances |
| Disabling Patentability for Skill-Based Inventions: Aligning Patent Law with Competition Policy - 455 occurances |
| Is the Patent Paradox a Result of a Large Firm Perspective? – Differential Value of Small Firm Patents Over Time Explains the Patent Paradox - 449 occurances |
| Debugging Software Patents: Increasing Innovation and Reducing Uncertainty in the Judicial Reform of Software Patent Law - 428 occurances |
| Calibrating Patent Lifetimes - 406 occurances |
| The History, Content, Application and Influence of the Northern District Of California’s Patent Local Rules - 404 occurances |
| The History, Content, Application and Influence of the Northern District Of California’s Patent Local Rules - 404 occurances |
| Pharmaceutical Reverse Payment Settlements: Presumptions, Procedural Burdens, and Covenants Not to Sue Generic Drug Manufacturers - 400 occurances |
| Pharmaceutical Reverse Payment Settlements: Presumptions, Procedural Burdens, and Covenants Not to Sue Generic Drug Manufacturers - 400 occurances |
| A Coherent View of Patent Exhaustion: A Standard Based on Patentable Distinctiveness - 381 occurances |
| Evaluating the Use of Patent Pools For Biotechnology: A Refutation to the USPTO White Paper Concerning Biotechnology Patent Pools - 370 occurances |
| Doubling Up the Horses in Midstream: Enhancing U.S. Patent Dispute Resolution by the PTO’s Adoption of the JPO’s Hantei Request System - 348 occurances |
| In Search of the Undiscovered Country: The Challenge of Describing Patentable Subject Matter - 342 occurances |
| Prospectively Curing Inequitable Conduct Through Reissue: Reconsidering A “Well-Settled Principle” - 335 occurances |
| Prospectively Curing Inequitable Conduct Through Reissue: Reconsidering A “Well-Settled Principle” - 335 occurances |
| Windfall Property Rights for the Left Out Co-Inventor Who Gets Let Into the Patent - 319 occurances |
| Understanding Patent Infringement Under 35 U.S.C. § 271(e): The Collisions Between Patent, Medical Device, and Drug Laws - 310 occurances |
| Proposing Resolutions to the Inssufficient Gene Patent System - 299 occurances |
| The Community Patent, or: How I Learned to Stop Worrying and Love the English Language - 294 occurances |
| Towards Developing a Natural Law Jurisprudence in the U.S. Patent System - 291 occurances |
| Nuisance-Value Patent Suits: An Economic Model and Proposal - 286 occurances |
| Business Methods and Patentable Subject Matter following In Re Bilski: is “Anything Under the Sun Made by Man” Really Patentable? - 284 occurances |
| Business Methods and Patentable Subject Matter following In Re Bilski: is “Anything Under the Sun Made by Man” Really Patentable? - 284 occurances |
| Patents: Hiding from History - 271 occurances |
| Reconciling Contract Doctrine with Intellectual Property Law: an Interdisciplinary Solution - 263 occurances |
| KSR: It Was Not A Ghost - 255 occurances |
| A Brief History of Indirect Liability for Patent Infringement - 227 occurances |
| Assignor Estoppel: Fairness at what Price? - 217 occurances |
| The Effect of International Comity on the Application of the Attorney-Client Privilege and Foreign Privilege Laws in U.S. Patent Litigation - 215 occurances |
| Biomedical Patenting: Permitted, But Permissible? - 198 occurances |
| A Case Against Software Patents - 197 occurances |
| Lessons from Laboratory Corp. of America Holdings v. Metabolite Laboratories, Inc. - 197 occurances |
| Is the Use of Patents Promoting the Creation of New Types of Securities? - 194 occurances |
| Representative Patent Claims: Their Use in Appeals to the Board and in Infringement Litigation - 191 occurances |
| Intellectual Property In Standards: Does Antitrust Law Impose A Duty To Disclose (Even If The Standards-Setting - 191 occurances |
| Intellectual Property In Standards: Does Antitrust Law Impose A Duty To Disclose (Even If The Standards-Setting - 191 occurances |
| Laws Of Nature And The Business Of Biotechnology - 190 occurances |
| Patent Rules of Evidence - 174 occurances |
| Intangible or Embodied Information: The Non-Statutory Nature of Human Genetic Material - 170 occurances |
| Intangible or Embodied Information: The Non-Statutory Nature of Human Genetic Material - 170 occurances |
| Patentability of Human-Animal Chimeras - 169 occurances |
| The Shifting Sands of Price Erosion: Price Erosion Damages Shift by Tens of Millions of Dollars Depending Upon the Admissibility of Pre-Notice Eroded Prices - 163 occurances |
| The Shifting Sands of Price Erosion: Price Erosion Damages Shift by Tens of Millions of Dollars Depending Upon the Admissibility of Pre-Notice Eroded Prices - 163 occurances |
| Application of the Inequitable Conduct Doctrine After Kingsdown - 159 occurances |
| Application of the Inequitable Conduct Doctrine After Kingsdown - 159 occurances |
| The “Right” To Injunctive Relief For Patent Infringement - 155 occurances |
| Open Source Biology: A Means to Address the Access & Research Gaps? - 150 occurances |
| "Real as Pro Wrestling"?: Johns Hopkins University v. CellPro and the Federal Court's Power of Review in Patent Infringement Actions. - 148 occurances |
| Current Patent Protection Granted for Genetically Modified Organisms under the European Patent Convention and the Scandal of EP 0695351 - 140 occurances |
| Injunctions Enjoined; Remedies Restructured - 136 occurances |
| Injunctions Enjoined; Remedies Restructured - 136 occurances |
| In re Cardizem and Valley Drug: A View from the Faultline Between Patent and Antitrust in Pharmaceutical Settlements - 131 occurances |
| Antitrust And Trade Secrets: The U.S. and the EU Approach - 125 occurances |
| Are Business Method Patents Bad For Business? - 123 occurances |
| Schering Corp. v. Geneva Pharmaceuticals, Inc.: Just How Far can Inherent Anticipation Extend? - 121 occurances |
| Source Code Versus Object Code: Patent Implications for the Open Source Community - 119 occurances |
| Finding The Patent Infringement “Mastermind”: The “Control Or Direction” Standard For “Joint” Infringement - 109 occurances |
| Finding The Patent Infringement “Mastermind”: The “Control Or Direction” Standard For “Joint” Infringement - 109 occurances |
| Transaction Costs and Patent Reform - 107 occurances |
| RF Delaware, Inc. v. Pacific Keystone Technologies, Inc.: The Federal Circuit Has Finally Spoken on Collateral Estoppel of Claim Interpretation - 101 occurances |
| § 112, ¶ 6 Claim Interpretation and the Doctrine of Equivalents: An Invitation to Confused Thinking - 98 occurances |
| Protecting Academic and Non-Profit Research: Creating a Compulsory Licensing Provision in the Absence of an Experimental Use Exception - 98 occurances |
| De Novo Review of Claims Construction or a Wasted Effort of the District Court: Interactive Gift Express, Inc. v. Compuserve, Inc. - 91 occurances |
| Territorial Impact Factors: An Argument For Determining Patent Infringement Based Upon Impact on the U.S. Market - 90 occurances |
| Necessity May be the Mother of Invention, but Who Gets Custody?: The Ownership of Intellectual Property Created by an Employed Inventor - 90 occurances |
| Fishing for Utility with Expressed Sequence Tags After In re Fisher - 87 occurances |
| Improvements for Handling Improvement Clauses in IP Licenses: An Analytical Framework - 84 occurances |
| Declaratory Judgment Practices After SanDisk v. STMicroelectronics - 82 occurances |
| Florida Prepaid v. College Savings: United States Supreme Court Supports State Immunity From Suit Under Federal Patent Law - 78 occurances |
| Biotechnology: Highlights of the Science and Law Shaping the Industry - 78 occurances |
| Florida Prepaid v. College Savings: United States Supreme Court Supports State Immunity From Suit Under Federal Patent Law - 78 occurances |
| Internet Distribution of Intellectual Property Protected Works in the United States, in Japan, and in the Future - 77 occurances |
| Controlling Patent Rights In The Industry Standard Context: Micron Technology, Inc. v. Rambus Inc. - 75 occurances |
| The Test of Primary Cloning: A New Approach to the Written Description Requirement in Biotechnological Patents - 70 occurances |
| Trade Secret Law: An Impediment to Trade in Computer Software - 65 occurances |
| Patent Prosecution in Proteomics - 63 occurances |
| Seagate Equals Sea Change: The Federal Circuit Establishes a New Test For Proving Willful Infringement and Preserves the Sanctity of the Attorney-Client Privilege - 62 occurances |
| Reasonable Pricing – A New Twist for March-In Rights Under the Bayh-Dole Act - 60 occurances |
| An Essay on Women and Intellectual Property Law: The Challenges Faced by Female Attorneys Pursuing Careers in Intellectual Property - 58 occurances |
| International Intellectual Property, Progress, and the Rule of Law - 53 occurances |
| The Doctrine of Equivalents: An Analysis of the Festo Decision - 52 occurances |
| Joint Infringement of Patent Claims: Advice for Patentees - 52 occurances |
| Human Tissue Research: Who Owns the Results? - 50 occurances |
| Control of Inventions in a Networked World - 49 occurances |
| The Intent Element of Induced Infringement - 48 occurances |
| Wang Laboratories, Inc. v. America Online, Inc. And Netscape Communications Corp. - 46 occurances |
| The Supreme Court's Complicity in Federal Circuit Formalism - 46 occurances |
| The Toro Company v. White Consolidated Industries, Inc. - 38 occurances |
| The Toro Company v. White Consolidated Industries, Inc. - 38 occurances |
| Honeywell International, Inc. v. U.S. International Trade Commission - 36 occurances |
| International Waivers of Privilege and the Opinion of Counsel: Can the Scope of Disclosure be Managed? - 33 occurances |
| Intellectual Property Strategy in Bioinformatics and Biochips - 32 occurances |
| Intergraph Corporation v. Intel Corporation - 20 occurances |
| Atmel Corporation v. Information Storage Devices, Inc. - 20 occurances |
| Atmel Corporation v. Information Storage Devices, Inc. - 20 occurances |
